Physician profile
Alan S Waitze
NPI 1164480323
$67,132.38
in general payments reported to CMS, 2019-2025
16 companies · $218 in 2025
The $218 reported for 2025 was less than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42K · 2020: $2,983 · 2021: $7,692 · 2022: $8,883 · 2023: $3,859 · 2024: $1,546 · 2025: $218.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $3,282 · Food and Beverage: $2,340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $3,282.11 |
| Food and Beverage | $2,340.18 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $30,144.16 | 2019-2022 | |
| Integrity Implants INC. | $29,230.57 | 2019-2022 | Flarehawk |
| Integrity Implants INC. Dba Accelus | $3,282.11 | 2023-2024 | Flarehawk |
| Globus Medical, INC. | $1,694.42 | 2022-2025 | Excelsius3d Imaging System, Excelsiusgps Robotic Navigation System, Coalition Agx / Agx Rp |
| Cerapedics INC. | $1,220.15 | 2021-2024 | I-Factor Peptide Enhanced Bone Graft |
| Ulrich Medical USA, INC. | $362.60 | 2019-2021 | |
| Si-Bone, INC. | $350.17 | 2019-2023 | |
| Ctl Medical Corporation | $193.97 | 2021 | |
| Orthofix Medical, INC. | $111.76 | 2019 | |
| Avanos Medical | $102.65 | 2019 | |
| Djo, LLC | $97.22 | 2019 | |
| Boston Scientific Corporation | $95.53 | 2019 | |
| Abbott Laboratories | $93.88 | 2019 | |
| Depuy Synthes Sales INC. | $78.88 | 2023 | Fibergraft Bg Morsels |
| Painteq LLC | $51.95 | 2024 | Painteq |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Highridge Medical LLC | $22.36 | 2024 | Spf Xl Iib Implantable Spinal Fusion Stimulator, Biomet Spinalpak Non-Invasive Spine Fusion Stimulator System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alan Waitze listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.